John D. Ulm

Array ( [id] => 4221354 [patent_doc_number] => 06010884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Recombinant binding proteins and peptides' [patent_app_type] => 1 [patent_app_number] => 8/654623 [patent_app_country] => US [patent_app_date] => 1996-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 20156 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010884.pdf [firstpage_image] =>[orig_patent_app_number] => 654623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3714352 [patent_doc_number] => 05616477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Fusion proteins comprising GM-CSF and antigens and their expression in yeast' [patent_app_type] => 1 [patent_app_number] => 8/641704 [patent_app_country] => US [patent_app_date] => 1996-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10235 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616477.pdf [firstpage_image] =>[orig_patent_app_number] => 641704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174154 [patent_doc_number] => 06036978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Controlled release polypeptide compositions and methods of treating inflammatory bowel disease' [patent_app_type] => 1 [patent_app_number] => 8/636841 [patent_app_country] => US [patent_app_date] => 1996-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4158 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036978.pdf [firstpage_image] =>[orig_patent_app_number] => 636841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3836026 [patent_doc_number] => 05846823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Expression of human D4 dopamine receptors in stable cell lines' [patent_app_type] => 1 [patent_app_number] => 8/623471 [patent_app_country] => US [patent_app_date] => 1996-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7350 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846823.pdf [firstpage_image] =>[orig_patent_app_number] => 623471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777247 [patent_doc_number] => 05817760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Human A3 adenosine receptors' [patent_app_type] => 1 [patent_app_number] => 8/560231 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 11304 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817760.pdf [firstpage_image] =>[orig_patent_app_number] => 560231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757394 [patent_doc_number] => 05843675 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'TNF receptor death domain ligand proteins and inhibitors of ligand binding' [patent_app_type] => 1 [patent_app_number] => 8/602228 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13653 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843675.pdf [firstpage_image] =>[orig_patent_app_number] => 602228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3954126 [patent_doc_number] => 05935824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Protein expression system' [patent_app_type] => 1 [patent_app_number] => 8/595043 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 53 [patent_no_of_words] => 58747 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935824.pdf [firstpage_image] =>[orig_patent_app_number] => 595043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032652 [patent_doc_number] => 05856098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Detection of a leptin receptor variant' [patent_app_type] => 1 [patent_app_number] => 8/588190 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5707 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856098.pdf [firstpage_image] =>[orig_patent_app_number] => 588190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355376 [patent_doc_number] => 06218356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Neural receptor tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/542635 [patent_app_country] => US [patent_app_date] => 1995-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 53 [patent_no_of_words] => 28693 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218356.pdf [firstpage_image] =>[orig_patent_app_number] => 542635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379475 [patent_doc_number] => 06277591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Dopamine receptors and genes' [patent_app_type] => 1 [patent_app_number] => 8/480390 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 59 [patent_no_of_words] => 10201 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277591.pdf [firstpage_image] =>[orig_patent_app_number] => 480390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4231667 [patent_doc_number] => 06117656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Cloned genes encoding IG-CD4 fusion proteins and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/479353 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18419 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117656.pdf [firstpage_image] =>[orig_patent_app_number] => 479353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106591 [patent_doc_number] => 06100446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Microorganisms and plasmids for 2,4-dichlorophenoxyacetic acid (2,4-D)monooxygenase formation and process for the production of these plasmids and strains' [patent_app_type] => 1 [patent_app_number] => 8/470588 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19641 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100446.pdf [firstpage_image] =>[orig_patent_app_number] => 470588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016153 [patent_doc_number] => 05880260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Dopamine receptors and genes' [patent_app_type] => 1 [patent_app_number] => 8/474892 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 59 [patent_no_of_words] => 25360 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880260.pdf [firstpage_image] =>[orig_patent_app_number] => 474892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645672 [patent_doc_number] => 07119182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Recombinant thrombin receptor and related pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 08/481896 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15318 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119182.pdf [firstpage_image] =>[orig_patent_app_number] => 08481896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027730 [patent_doc_number] => 05883226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Human dopamine receptor and its uses' [patent_app_type] => 1 [patent_app_number] => 8/487811 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 11995 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883226.pdf [firstpage_image] =>[orig_patent_app_number] => 487811 [rel_patent_id] =>[rel_patent_doc_number] =>)